
Opinion|Videos|October 4, 2024
Overcoming Barriers in ART
Author(s)Jeffrey Dunn, PharmD, MBA
Jeffrey Dunn, Pharm.D., MBA, discusses how the overall issues for assisted reproductive technologies (ARTs) encompass a range of challenges, including access, affordability, efficacy and ethical considerations, and the need for continued research and improvement in treatment protocols
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What do you see as overall issues for assisted reproductive technology?
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Inside the DUPLEX Trial: FSGS Design, Endpoints, and Exclusions
2
Corticosteroids, RAS Inhibitors, or Sparsentan First for FSGS?
3
Prior authorization isn’t shrinking. Its savings are
4
David Chen, Pharm.D., on Kaiser Permanente's biosimilar strategy
5
























